Gene editing is difficult and, until now, has relied on different types of viral vectors to deliver a working copy of a gene into human cells. Prime, or base, editing offers a more direct way to edit human cells.
Systemic lupus erythematosus (SLE) is hard to diagnose. The average time and route to diagnosis is six years and four doctors. New imaging techniques could shorten that journey.
Many human diseases are not easily accessible to current methods of editing DNA through CRISPR (clustered regularly interspaced short palindromic repeats), the bacterial defense system.
The COVID-19 pandemic has catalyzed DCT adoption among sponsors and may prove to be the long-term inflection point.
The New York Stem Cell Foundation predicts that iPS cells will enable a new era in personalized medicine in which stem cells can be turned into your own biobank to replace whatever cells you’re missing.